Olanzapine versus aprepitant for the prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving doxorubicin-cyclophosphamide regimen: A prospective, nonrandomized, open-label study

Saved in:
Bibliographic Details
Published in:Indian Journal of Pharmacology 2017, Vol.49 (6), p.451
Main Authors: Shivaprakash, G, Udupa, Karthik, Sarayu, V, Thomas, Joseph, Gupta, Vishal, Pallavi, L, Pemminati, Sudhakar
Format: Report
Language:English
Subjects:
Aprepitant
Breast cancer
Cancer patients
Chemotherapy
Comparative analysis
Complications and side effects
Cyclophosphamide
Dosage and administration
Doxorubicin
Drug therapy
Nausea
Olanzapine
Patient outcomes
Prophylaxis
Vomiting
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0253-7613